Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 26.70
0.00 (-0.37%)
Jul 21, 2026, 2:31 PM CST
Genovate Biotechnology Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 471.48 | 492.41 | 510.86 | 528.51 | 438.76 | 434.25 |
Revenue Growth | -6.23% | -3.61% | -3.34% | 20.46% | 1.04% | -8.14% |
Gross Profit Gross Profit Growth | 163.03 | 177.02 | 192.65 | 210.92 | 154.87 | 149.75 |
Operating Income Operating Income Growth | -17.22 | 6.92 | 23.43 | 27.01 | -13.89 | -1.17 |
Net Income Net Income Growth | -9.17 | 11.68 | 25.7 | 29.33 | -12.32 | 0.37 |
Earnings Per Share EPS Growth | -0.08 | 0.10 | 0.22 | 0.25 | -0.11 | 0.00 |
EPS Growth | - | -54.55% | -13.69% | - | - | -99.15% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Taiwan Taiwan Growth | 483.82 | 505.74 | 519.35 | 435.22 | 429.86 |
Other Other Growth | 8.58 | 5.12 | 9.16 | 3.54 | 4.4 |
Total Total Growth | 492.41 | 510.86 | 528.51 | 438.76 | 434.25 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,111 | 481.96 | 521.47 | 539.3 | 497.05 | 389.42 |
Total Debt Total Debt Growth | 1.57 | 1.84 | 2.58 | 0.68 | 1.84 | 0.83 |
Net Cash (Debt) Net Cash Growth | 1,109 | 480.12 | 518.88 | 538.62 | 495.21 | 388.59 |
Net Cash Growth | 119.86% | -7.47% | -3.66% | 8.77% | 27.44% | -7.29% |
Net Cash Per Share Net Cash Per Share Growth | 9.45 | 4.22 | 4.52 | 4.68 | 4.37 | 3.43 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1.81 | 43.79 | 55.11 | 84.78 | 1.51 | -17.26 |
Capital Expenditures CapEx Growth | -38.1 | -55.73 | -30.78 | -27.98 | -23.55 | -17.96 |
Free Cash Flow Free Cash Flow Growth | -36.29 | -11.94 | 24.34 | 56.81 | -22.04 | -35.22 |
Free Cash Flow Growth | - | - | -57.16% | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 34.58% | 35.95% | 37.71% | 39.91% | 35.30% | 34.48% |
Operating Margin | -3.65% | 1.40% | 4.59% | 5.11% | -3.17% | -0.27% |
Pretax Margin | -2.15% | 2.73% | 6.08% | 5.83% | -2.05% | 0.82% |
Profit Margin | -1.94% | 2.37% | 5.03% | 5.55% | -2.81% | 0.09% |
FCF Margin | -7.70% | -2.42% | 4.76% | 10.75% | -5.02% | -8.11% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.098 | - | 0.100 | 0.143 | 0.167 | 0.333 |
Dividend Per Share Growth | -32.00% | - | -29.97% | -14.29% | -49.98% | -12.94% |
Dividend Yield | 0.37% | - | 0.51% | 0.59% | 0.57% | 1.50% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 269.72 | 90.45 | 99.18 | - | 7191.72 |
Forward PE | - | 38.71 | 38.71 | 38.71 | 38.71 | 38.71 |
P/FCF Ratio | - | - | 95.52 | 51.22 | - | - |
PS Ratio | 7.74 | 6.40 | 4.55 | 5.51 | 7.99 | 6.16 |